SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027602
Filing Date
2021-05-13
Accepted
2021-05-13 16:33:26
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hsto-10q_20210331.htm   iXBRL 10-Q 2104980
2 EX-31.1 hsto-ex311_7.htm EX-31.1 21255
3 EX-31.2 hsto-ex312_6.htm EX-31.2 21311
4 EX-32.1 hsto-ex321_8.htm EX-32.1 8430
5 EX-32.2 hsto-ex322_9.htm EX-32.2 8455
  Complete submission text file 0001564590-21-027602.txt   7934051

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA hsto-20210331.xsd EX-101.SCH 70087
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hsto-20210331_cal.xml EX-101.CAL 61865
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hsto-20210331_def.xml EX-101.DEF 216296
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20210331_lab.xml EX-101.LAB 519850
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20210331_pre.xml EX-101.PRE 377591
11 EXTRACTED XBRL INSTANCE DOCUMENT hsto-10q_20210331_htm.xml XML 1202930
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 21920170
SIC: 2834 Pharmaceutical Preparations